Fig. 2
From: A Journey in Science: Immersion in the search for effective cancer immunotherapies
Examples of the earliest complete responses to IL-2 administration that ultimately led to the first FDA approval of a cancer immunotherapy (upper panels, melanoma; lower panels, renal cancer)